Beaumont Financial Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,263
Closed -$207K 227
2017
Q4
$207K Sell
1,263
-680
-35% -$122K 0.02% 179
2017
Q3
$398K Sell
1,943
-23
-1% -$5.35K 0.05% 128
2017
Q2
$478K Sell
1,966
-286
-13% -$67.2K 0.06% 115
2017
Q1
$538K Buy
+2,252
New +$524K 0.07% 113
2015
Q2
Sell
-3,657
Closed -$1.09M 160
2015
Q1
$1.09M Sell
3,657
-19,592
-84% -$5.59M 0.04% 95
2014
Q4
$5.99M Sell
23,249
-343
-1% -$85.7K 0.29% 72
2014
Q3
$5.69M Sell
23,592
-652
-3% -$146K 0.37% 68
2014
Q2
$5.41M Buy
24,244
+3,775
+18% +$782K 0.38% 70
2014
Q1
$4.21M Buy
+20,469
New +$4.05M 0.35% 64

Other funds holding AGN

Beaumont Financial Advisors's AGN Position: Q1 2018 in Review

Beaumont Financial Advisors sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 1,263 shares — an estimated $207K sold.

Beaumont Financial Advisors first reported a position in AGN in Q1 2014 and held it in 9 quarters. The position peaked at $5.99M in Q4 2014. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • Beaumont Financial Advisors reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Beaumont Financial Advisors sold 1,263 Allergan plc shares in Q1 2018, an estimated $207K.
  • Beaumont Financial Advisors first reported a position in Allergan plc in Q1 2014 and held it in 9 quarters.
  • Beaumont Financial Advisors's Allergan plc position peaked at $5.99M in Q4 2014.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Beaumont Financial Advisors's 13F filing for Q1 2018, filed 11 May 2018.